Introduction
Apoptosis is a genetically programmed process by which cells die in response to defined stimuli, and which is critical for multicellular organisms in development and tissue homeostasis (Hengartner, 2000) . The principle mediators of apoptosis are members of the caspase family of cysteine proteases (Degterev et al., 2003) . At least two different signaling pathways that lead to activation of caspases have been described (Degterev et al., 2003) . In the extrinsic pathway, apoptosis is activated by ligand binding to death receptors on the cell surface, leading to the formation of the death-inducing signaling complex (DISC) and activation of caspase-8 (Ashkenazi, 2002) . The main step in the intrinsic pathway is activation of mitochondria, release of cytochrome c and subsequently formation of the apoptosome containing cytochrome c, caspase-9 and Apaf-1 (Saelens et al., 2004) . This complex supports the catalytic activation of caspase-9, which further cleaves and activates caspase-3, leading to cleavage of cellular death substrates and apoptosis (Saelens et al., 2004) . Caspase activity is negatively regulated by inhibitor of apoptosis proteins (IAPs), which are characterized by one or more baculovirus IAP repeat (BIR) (Salvesen and Duckett, 2002 ). An important function of IAPs, whose most prominent member is X-linked inhibitor of apoptosis protein (XIAP), is to antagonize caspases by binding to and inhibiting caspase-9, -3 and -7 (Salvesen and Duckett, 2002) .
Besides cytochrome c, several proapoptotic proteins are released from mitochondria including apoptosisinducing factor (AIF), endonuclease G, Omi and second mitochondria derived activator of caspases (Smac) (Saelens et al., 2004) . Smac is synthesized as a precursor containing an N-terminal 55-residue mitochondrial targeting sequence, which is cleaved upon import into the mitochondria to generate the mature form (Vaux and Silke, 2003) . Upon release from mitochondria to the cytosol, Smac promotes caspase activation by antagonizing IAP-mediated inhibition of caspases (Vaux and Silke, 2003) . Interaction of Smac with the BIR2 and BIR3 domain of XIAP has been previously mapped to the N-terminal amino acids of the mature Smac protein, and removal of this region blocked the ability to bind XIAP Wu et al., 2000; Shiozaki and Shi, 2004) . However, there is also evidence that the proapoptotic function of Smac may not be restricted to the ability to inhibit IAPs. To this end, Smacb, a splice variant that lacks the N-terminal domain responsible for IAPs binding, remains capable of potentiating apoptosis (Roberts et al., 2001 ).
Smac agonists in combination with apoptotic stimuli have been described to sensitize cancer cells for apoptosis in vitro and also to inhibit tumor cell growth in vivo (Fulda et al., 2002; Guo et al., 2002; Yang et al., 2003; Pei et al., 2004) . Besides its function as an apoptosissensitizer, the question whether or not Smac on its own in the absence of a proapoptotic stimulus has an effect on tumor cell viability has been controversially discussed. Several reports have shown that overexpression of Smac did not on its own induce apoptosis in tumor cell lines, even when overexpressed as a mature form in the cytosol of mammalian cells or administered as peptides (Fulda et al., 2002; Guo et al., 2002; Ng and Bonavida, 2002; Yang et al., 2003) . However, ectopic expression of Smac alone was found to reduce cell survival and to induce apoptosis by other investigators (McNeish et al., 2003 (McNeish et al., , 2005 Hasenjager et al., 2004) . Therefore, to further characterize the effect of Smac on tumor cell viability we engineered a panel of different cancer cell lines including neuroblastoma, glioblastoma, pancreatic and colon carcinoma to overexpress Smac. Here we report that overexpression of Smac inhibits clonogenic tumor cell growth by restraining random migration, by enhancing apoptosis and by inhibiting proliferation in a cell density and cell type specific manner.
Results

Smac inhibits clonogenic tumor growth of SH-EP neuroblastoma cells at low density
Smac agonists have been reported to promote apoptosis in a variety of cell types by releasing the inhibitory action of IAPs on activation of effector caspases. However, the question whether Smac itself in the absence of apoptotic stimuli interferes with cell viability has remained unclear. Therefore, to investigate the role of Smac in tumor cell viability, we stably transduced a set of tumor cell lines derived from glioblastoma (LN229, U87MG), neuroblastoma (SH-EP, SH-SY5Y, Kelly), colon carcinoma (HCT116) and pancreatic cancer (ASPC1, PaTuII) with full-length, C-terminal Flag-tagged Smac, which contains the N-terminal mitochondrial-targeting sequence that is cleaved off after import into mitochondria (Vaux and Silke, 2003) . Upon ectopic expression, Smac is predominantly present in the processed 24 kD form, indicating spontaneous processing of 28 kD full-length Smac (Figure 1a) . Endogenous Smac was present in the processed form of slightly lower molecular weight (23 kD) than Flagtagged Smac as revealed using anti-Smac antibody, indicating that endogenous Smac was completely processed to mature Smac (Figure 1a ). In most cell types, no changes in expression levels of XIAP, cIAP2 or Survivin protein were observed in Smac-transduced cells with the exception of U87MG glioblastoma cells showing upregulation of XIAP expression upon overexpression of Smac, and ASPC1 pancreatic carcinoma cells showing downregulation of XIAP expression upon overexpression ( Figure 1a) . We observed upregulation of survivin in Smac-transduced SH-SY5Y cells and downregulation of survivin upon overexpression of Smac in HCT116 cells (Figure 1a ), which may, however, also be due to differences in cell cycle distribution in nonsynchronized cells.
To investigate whether Smac has an influence on tumor cell viability we measured spontaneous apoptosis and proliferation. No differences in apoptosis, proliferation or tumor cell growth were observed in cells expressing vector control or Smac when cultured at relatively high cell density (0.2 Â 10 5 cells/cm 2 ) ( Figure  1b-d) . To assess the effect of Smac on long-term survival of tumor cells, we performed clonogenic assay using limited dilution. Interestingly, we found a strongly reduced clonogenic capacity of SH-EP neuroblastoma cells overexpressing Smac as compared to vector control cells ( Figure 1e and Supplementary Figure 2c) . Notably, growth inhibition by Smac depended on cell density, since it was only observed at relatively low cell densities ( Figure 1e and Supplementary Figure 2c ). In contrast, Smac did not influence clonogenic capacity in all other cell lines tested ( Figure 1e and Supplementary Figure 2) , despite high expression levels of Smac in these cells (Figure 1a) . Therefore, to control functionality of the Smac construct, we investigated the effect of Smac overexpression on doxorubicin-induced apoptosis. Overexpression of Smac sensitized U87MG glioblastoma and SH-EP neuroblastoma cells to doxorubicin-induced apoptosis and neuroblastoma (SH-EP), glioblastoma (U87MG, LN229) and pancreatic cancer (ASPC-1, PaTuII) cells for g-irradiation-induced apoptosis ( Figure 1f and data not shown). These findings demonstrate that the growth-inhibitory effect of Smac was not strictly linked to its ability to sensitize for apoptosis.
Similar to retroviral transduction, ectopic expression of Smac by transfection, which yielded Smac levels comparable to those achieved by retroviral infection (Figure 2a ), impaired clonogenic capacity of SH-EP neuroblastoma cells (Figure 2c and Supplementary  Figure 2i ). In addition, processed SmacD55 lacking the mitochondrial targeting sequence, which predominantly localizes to the cytosol compared to full-length, mitochondrial Smac (Figure 2b ), similarly inhibited clonogenic capacity (Figure 2c and Supplementary Figure 2i ). We also extended our studies to various clones of SH-EP neuroblastoma cells overexpressing Smac or SmacD55, to exclude that the observed effect of Smac on clonogenic survival was the result of clonal selection. Inhibition of clonogenic survival at low cell densities was comparable in different clones overexpressing Smac or SmacD55 (Figure 2c and Supplementary Figure 2i ). This set of experiments indicates that both full-length and processed Smac regardless of transfection method or clonogenic status profoundly inhibited cell growth of SH-EP neuroblastoma cells at low cell density. For further experiments we selected pcDNA-transfected Smac clone 28 and SmacD55 clone 75.
To investigate whether overexpression of Smac has an influence on tumor formation in an in vivo setting, we cultured SH-EP neuroblastoma cells on the chorion allantois membrane (CAM) of chicken embryos and assessed tumor formation after 4 days by histological analysis. SH-EP neuroblastoma cells transfected with vector control formed tumors on the CAM of five out of 23 chicken embryos, while SH-EP cells overexpressing Smac formed tumors on the CAM of three out of 21 chicken embryos (P ¼ 0.27). Tumors derived from control or Smac-overexpressing SH-EP cells were similar in size and invasiveness as assessed by gross microscopy and histology (Figure 3 ), demonstrating (e) Clonogenic capacity of cells was investigated using limited dilution. Cells were seeded at the indicated cell numbers/well and colonies were stained with crystal-violet after 7 days of culture. (f) Neo (black bars) or Smac-overexpressing (hatched bars) cells were treated with doxorubicin at the indicated concentrations for 48 h (LN229, SH-EP, SH-SY5Y, Kelly, HCT116, ASPC1, PaTuII) or 72 h (U87MG). Viability was determined using MTT assay and expressed as percentage of untreated controls. For statistical analysis, t-test was performed comparing vector control to Smac-transduced cells (*Po0.05, **Po0.001). In (b-d) and (f), mean þ s.d. of three independent experiments performed in triplicates are shown Smac-induced growth inhibition M Vogler et al that overexpression of Smac did not significantly inhibit tumor formation in vivo. Due to the high initial cell density necessary for tumor formation in the CAM assay (1 Â 10 6 cells), low cell density could not be tested in this assay.
Smac inhibits motility and random migration at low cell density
The results obtained in clonogenic assay (Figure 1e ) suggest that cell density is a crucial determinant of growth inhibition by Smac. To gain insight into the mechanism of growth inhibition by Smac we performed time lapse microscopy over 48 h. When seeded at low cell density (0.5 Â 10 4 cells/cm 2 ), corresponding to the density at which SH-EP neuroblastoma cells are able to form colonies, while SH-EP cells overexpressing Smac have lost this ability (Figure 1e ), SH-EP neuroblastoma cells transfected with vector control were motile, divided and formed small clusters ( Figure 4a ). In contrast, Smac overexpressing SH-EP neuroblastoma cells were only motile for the first 6 h, but did not find cell-cell contact and arrested their movements without further division ( Figure 4a ). Thus, an increase in cell number and colony formation after 48 h was only observed in vector control, but not in Smac-transfected cells ( Figure 4a ).
To further investigate the effect of Smac on cell motility we performed migration assay using transwell chambers containing complete medium without chemoattractants. Interestingly, we found that overexpression of Smac or SmacD55 significantly inhibited random migration ( Figure 4b ). Thus, we can conclude that overexpression of Smac suppressed random migration and motility under conditions where cell-cell contact is absent.
Smac promotes apoptosis and inhibits proliferation at low cell density
To quantify cell growth, cells were cultured at low cell density and counted for the following 4 days. While vector control cells showed exponential growth, cell counts of both Smac-or SmacD55-transfected SH-EP Since previous studies showed that Smac acts by relieving inhibition of caspases by IAPs, we asked whether inhibition of proliferation and/or triggering of apoptosis involved caspases. Addition of the broad-range caspase inhibitor zVAD.fmk (benzyloxycarbonyl-ValAla-Asp-fluoromethylketone) partly inhibited apoptosis in Smac-transfected cells, suggesting that both caspasedependent and -independent pathways were involved ( Figure 5b ). We also tested the effect of zVAD.fmk on proliferation, since caspases have been implicated in the regulation of proliferation (Degterev et al., 2003) . However, addition of zVAD.fmk had no effect on Smacmediated blockade of proliferation (Figure 5c ). Western blot analysis revealed no processing of caspase-3, -8 or -9, while procaspase-2 levels decreased in cells overexpressing Smac or SmacD55 at low cell density (Figure 5d ). No caspase-2 or -3 activity was detected in vector control or Smac-transfected cells as determined by enzymatic caspase assay (Figure 5e Smac enhances polynucleation at low cell density
Next, we asked whether growth arrest induced by Smac was due to cell cycle arrest and/or induction of senescence. Analysis of cell cycle distribution revealed no cell cycle arrest in SH-EP cells overexpressing Smac or SmacD55 (Figure 6a ). In addition, no senescenceassociated-bGal (SA-bGal) positive cells and no morphological signs of senescence, for example, flat and enlarged cells, were detectable in Smac-transfected cells after 3 days of low cell density culture (Figure 6b ). Additionally, we found no increase in p21 protein, which is often upregulated in cells undergoing senescence (Figure 6c ), further supporting the notion that the growth-inhibitory effect of Smac was not mediated by induction of senescence. In fact, expression of p21 protein was decreased in Smac-transfected cells at low cell density (Figure 6c ). To test for a defect in cytokinesis or mitosis, we stained SH-EP neuroblastoma cells grown for 3 days at low cell density with ToPro3-iodide and counted the number of multinucleated cells (Figure 6e, f) . Interestingly, the percentage of polynuclear cells increased in Smac-transfected cells with no signs of cell death, indicating that defects in cytokinesis may be involved in growth arrest of SH-EP cells overexpressing Smac or SmacD55 at low cell density. 
Smac inhibits protein expression at low cell density
Since the only known direct interaction partners of Smac are IAP proteins, which function not only in regulation of apoptosis, but also of mitosis, we asked whether growth arrest by Smac may involve IAPs. Interestingly, we found reduced expression of Survivin and of XIAP protein in Smac-transfected cells at low cell density (Figure 7a ). To investigate whether Smac selectively affects expression of IAPs, we also assessed other proteins. Notably, expression of other proteins not supposed to be directly regulated by Smac such as FLICE inhibitory protein (FLIP) (Figure 7a ), caspase-2 (Figure 5d ) or p21 (Figure 6c ) also decreased under these low-density conditions, indicating that Smac globally affected protein expression. To further elucidate whether Smac alters protein expression at the transcriptional or post-transcriptional levels, we determined mRNA expression by semiquantitative RT-PCR. No differences were found in mRNA levels of Survivin, XIAP, caspase-2 or p21 in SH-EP neuroblastoma cells transfected with vector control, Smac or SmacD55 (Figure 7b ). To investigate whether Smac enhances protein degradation through the proteasomal pathway, we used the proteasomal inhibitor MG132. Notably, addition of MG132 did not prevent downregulation of protein expression of Survivin, XIAP, FLIP, p21 or caspase-2 in Smac-transfected cells cultured under low cell density (Figure 7d ). Together, this set of experiments indicates that downregulation of protein expression of Survivin, XIAP, FLIP, p21 or caspase-2 in Smactransfected cells cultured under low cell density was neither due to suppression of mRNA expression nor enhanced proteasomal degradation. 
Growth arrest by Smac is reversible
The fact that the growth-inhibitory effect of Smac in SH-EP neuroblastoma cells becomes only evident at low cell density suggested that signals provided by the microenvironment, for example, those delivered by cell adhesion molecules, extracellular matrix proteins and/or growth factors, may play a role. However, no differences in cell adhesion molecules such as Integrinb1, Integrina5 or neuronal cell adhesion molecule (NCAM) were detected between SH-EP neuroblastoma cells transfected with vector control, Smac or SmacD55 (Figure 8a-c) . Additionally, neither supply of the extracellular matrix component fibronectin nor conditioned medium rescued the loss of clonogenic capacity due to overexpression of Smac or SmacD55 (Figure 8d , e and Supplementary Figure 2f) . Also, we found no apparent differences in expression or phosphorylation of AKT in Smac-transfected SH-EP neuroblastoma cells under low cell density compared to vector control cells, indicating that the growth defect in Smac-transfected cells under low density is not likely due to a lack of survival signaling via the AKT pathway (Supplementary Figure 1) . Since growth impairment by Smac strictly depended on cell density, we then tested whether growth arrested cells can be rescued by increasing cell density. To this end, we replated cells at 12 times higher density after culture at low cell density for 3 or 4 days to induce Smac-mediated growth arrest. Intriguingly, Smac-or SmacD55-transfected SH-EP neuroblastoma cells resumed growth upon replating at high cell density (Figure 8f, g ). Thus, these findings demonstrate that growth impairment by Smac was reversible.
Discussion
While the apoptosis promoting ability of Smac has been reported in response to various apoptosis inducers, the (Fulda et al., 2002; Guo et al., 2002; Ng and Bonavida, 2002; Yang et al., 2003) . We therefore investigated the role of Smac in regulating tumor cell viability in the present study. Here we report that overexpression of Smac inhibits clonogenic tumor cell growth by restraining random migration, by enhancing apoptosis and by inhibiting proliferation in a cell density and cell type dependent manner.
Interestingly, inhibition of clonogenic survival of SH-EP neuroblastoma cells by Smac strictly depended on low cell density and was reversed by replating cells at high density. Also, no defective tumor cell growth was observed in an in vivo model when Smac-transfected cells were seeded at high cell density on the chick CAM. These findings suggest that survival signals provided by the microenvironment, for example, cell-cell contact, soluble growth factors and/or extracellular matrix components, may control growth of Smac-transfected cells. However, supply of conditioned medium or extracellular matrix proteins did not rescue defective growth imposed by Smac. Also, no differences in cell surface expression of integrins or cell adhesion molecules were detected in Smac-transfected cells compared to vector control cells, indicating that cell-cell contacts may be involved. In support of this notion, we discovered that Smac inhibits cell motility and random migration under conditions, where cell-cell contacts are absent. Interestingly, the Drosophila inhibitor of apoptosis protein DIAP1 was recently identified as positive regulator of cell migration in a genetic screen for genes, which rescue the migration defect imposed by dominant-negative Rac in the Drosophila ovary (Geisbrecht and Montell, 2004) , providing for the first time a molecular link between IAPs and cell motility.
In addition to the barrier imposed by Smac on cell motility and random migration, Smac inhibited clonogenic capacity by enhancing apoptosis and by inhibiting proliferation. Smac-induced apoptosis under low cell density was partly inhibited by the broad range caspase inhibitor zVAD.fmk indicating that caspases were involved. Although procaspase-2 protein expression decreased in Smac-transfected cells when cultured at low density, no significant increase in caspase-2 enzymatic activity was detected. Since processed caspase-2 has recently been reported to induce apoptosis independent of its enzymatic activity (Robertson et al., 2004) , caspase-2 may mediate apoptosis in Smac-transfected cells under low density without requirement of its catalytic activity. Alternatively, other zVAD.fmk inhibitable protease(s) may be involved.
Recent evidence obtained in mammalian cells and Drosophila suggest that IAPs and Smac regulate each other at the level of protein expression, although it is yet unclear whether Smac positively or negatively affects ubiquitination of IAPs or vice versa (MacFarlane et al., 2002; Hu and Yang, 2003; Creagh et al., 2004; Silke et al., 2004; Yang and Du, 2004) . Interestingly, we found that Smac has a negative impact on global protein expression rather than selective degradation of IAPs at low cell density. Smac decreased protein expression of XIAP, survivin as well as other proteins such as FLIP, caspase-2 and p21, while their respective mRNA expression was not altered. Also, inhibition of the proteasomal protein degradation pathway did not prevent downregulation of these proteins in Smac-transfected cells, indicating that Smac may globally suppress protein expression at low cell density, a mechanism previously described for the Smac-homologue Reaper (Holley et al., 2002; Yoo et al., 2002) .
Besides their function in apoptosis some members of the IAP proteins, for example survivin, have also been described to influence proliferation (Altieri, 2003) . The proliferation defect we found in Smac-transfected cells did not exactly recapitulate the defects in mitosis and cytokinesis described for survivin depletion (Altieri, 2003) , although survivin protein expression decreased at low cell density in Smac-transfected cells. Overexpression of Smac resulted in appearance of polynuclear cells, whereas no signs of aberrant mitosis, for example polyploidy, were detected characteristically seen in survivin-depleted cells (Altieri, 2003) . These findings suggest that downregulation of survivin expression may not entirely account for the growth inhibitory effect of Smac. In addition to survivin, the IAP family protein Apollon/BRUCE has recently been implicated in regulation of cell division, which similar to survivin harbors a single survivin-like BIR domain (Hao et al., 2004) . Although growth arrest in tissue culture has been linked to withdrawal from cell cycle or senescence, we found no evidence that inhibition of proliferation in Smac-transfected cells involved cell cycle arrest and/or induction of senescence. Inhibition of proliferation in Smac-transfected cells may be the result of the negative impact of Smac on protein expression, which may globally retard cell doubling time without arrest in a specific cell cycle phase. In line with our data, Jia et al. (2003) described that Smac has a negative impact on proliferation in leukaemic cells.
Interestingly, the growth inhibitory effect of Smac could be distinguished from its apoptosis-promoting activity, as Smac sensitized glioblastoma and pancreatic carcinoma cells for doxorubicin-or g-irradiationinduced apoptosis, while it did not influence clonogenic capacity of these cells at low cell density. Inhibition of clonogenic capacity by Smac occurred independent of mitochondrial or cytosolic expression of Smac and independent of the transfection method in a cell type specific manner in SH-EP neuroblastoma cells. Ectopic expression of full-length Smac, although it predominantly localized to mitochondria, may also result in its partial release to the cytosol, in line with previous reports (McNeish et al., 2003; Hasenjager et al., 2004) , providing a possible explanation that both mitochondrial and cytosolic Smac inhibited clonogenic capacity. While no spontaneous apoptosis upon ectopic expression of mitochondrial or cytosolic Smac was previously observed using plasmid-based transfection protocols or retroviral vectors, adenoviral transduction of mitochondrial or cytosolic Smac has been reported to trigger apoptosis in the absence of an additional stimulus, which may be related to high gene expression levels achieved by adenoviral transduction and/or apoptosis-promoting effects of adenoviral proteins (McNeish et al., 2003 (McNeish et al., , 2005 Hasenjager et al., 2004) . In contrast to the mammalian system, Smac homologues in Drosophila, namely Hid, Grim and Reaper, trigger spontaneous apoptosis upon overexpression (Vaux and Silke, 2003) . Together, these findings suggest that the functional outcome of Smac expression may depend on the composition of positive and negative regulators of cell death in a cell type specific manner.
Our findings that Smac inhibits proliferation, cell motility and random migration in addition to promote apoptosis, thereby negatively regulating clonogenic growth of tumor cells may have important implications for control of tumor cell growth under conditions of low cell density or loss of cell-cell contact, for example, during tumor formation and/or metastasis. Thus, high Smac expression in tumor cells may pose a barrier on clonogenic tumor growth and/or its spread to distant organs during tumor progression. In support of this notion, disturbed balance of XIAP and Smac expression with relative increase of XIAP over Smac during tumor progression has recently been reported in renal cell carcinomas (Yan et al., 2004; Mizutani et al., 2005) . Clinically, control of metastatic disease or tumor relapse, which often originates from residual tumor cell spread to distant organs, still constitutes a major problem in oncology. Thus, our findings open new perspectives for the use of Smac agonists in cancer therapy, for example, in minimal residual disease.
Materials and methods
Cell culture and transfection SH-EP and Kelly neuroblastoma cells were cultured in RPMI 1640 medium (Life Technologies, Inc., Eggenstein, Germany), HCT116 colon carcinoma cells in McCoy's 5A medium (Life Technologies, Inc.) and SH-SY5Y neuroblastoma, LN229, U87MG glioblastoma, ASPC1 and PaTuII pancreatic carcinoma cells were cultured in DMEM (Life Technologies, Inc.) as described previously (Fulda et al., 1997) . All in vitro experiments were carried out in medium supplemented with 10% FCS (Biochrom, Berlin, Germany), 1 mM glutamine (Biochrom), 1% penicillin/streptavidin (Biochrom) and 25 mM HEPES (Biochrom). For experiments, cells were either cultured with 0.2 Â 10 5 /cm 2 (high cell density) or 0.5 Â 10 4 /cm 2 (low cell density). To inhibit proteasomal activity MG132 (Calbiochem, Schwalbach, Germany) was added at 100 nM. Infection was carried out using pLXIN retroviral transduction system (Sigma, St Louis, MO, USA) and PT67 packaging cell line (BD Biosciences Clonetech, Heidelberg, Germany), according to the manufacturer's instructions. Briefly, Smac was cloned from pBluescript KS þ in pLXIN vector (pLSmacIn) using restriction enzymes XhoI and BamHI (New England Biolabs, Beverly, MA, USA). PT67 cells were transfected with pLXIN empty vector or pLSmacIN using Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany). After selecting transfected PT67 cells with 500 mg/ml Geneticin G418 (Invitrogen) for 10 days, virus-containing supernatant was transferred to LN229, U87MG, SH-EP, SH-SY5Y, Kelly, HCT116, ASPC1 or PaTuII cells. Stable bulk cultures were generated by selection with G418, and ectopically expressed Smac protein was controlled by Western blotting. Alternatively, stable transfection of SH-EP neuroblastoma cells was carried out with pcDNA3 vector containing Smac or pcDNA3.1 containing SmacD55 as described previously (Srinivasula et al., 2000; Fulda et al., 2002) . Clones expressing pcDNA3.1 containing Smac or SmacD55 were selected by limited dilutions.
Western blotting
Western blot analysis was performed as described previously (Fulda et al., 1997) Determination of apoptosis, cell viability and proliferation
Apoptosis was determined by fluorescence-activated cellsorting (FACScan, Becton Dickinson, Heidelberg, Germany) analysis of DNA fragmentation of propidium iodide-stained nuclei as described previously (Fulda et al., 1997) . After stimulation with doxorubicin (Sigma), cell viability was assessed using MTT assay according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). Proliferation was measured as incorporation of H3-Thymidine. Briefly, cells were labeled with 1 mCi/well in 96-well plates overnight and afterwards lysed at À201C. After harvesting cells, counts were measured using Top Count NXT (Perkin-Elmer, Boston, MA, USA). To analyse tumor cell growth, cells were taken out of culture and counted in 1 : 100 dilution at Casy NT (Scha¨rfe System, Reutlingen, Germany), according to the manufacturer's instructions. For clonogenic assay, cells were seeded at the indicated numbers in 96-well plates coated with or without fibronectin (Sigma). After 8 days, the colonies were stained with 0.75% crystal violet, 50% ethanol, 0.25% NaCl and 1.57% formaldehyde. Representative pictures of at least three independent experiments are shown.
Migration assay
Random migration was analysed using 24-well Costar Transwell plates (Corning, NY, USA) with 8 mm pore size, according to the manufacturer's instructions. Both upper and lower chamber contained complete RPMI 1640. Cells were seeded in upper chamber at 0.5 Â 10 4 /cm 2 and migrated for 24 h to the lower chamber. Membranes were fixed with 4% paraformaldehyde and stained with HOECHST dye (HOECHST AG, Frankfurt, Germany). Numbers of migrated cells on the whole membrane were counted and vector control cells were taken as 100%.
Caspase activity
To determine caspase-3 activity we used DEVD-D2R (AspGlu-Val-Asp-Rhodamin) (Molecular Probes, Karlsruhe, Germany). Nonfixed cells (5 Â 10 5 ) were incubated with 100 mM DEVD-D2R at 371C for 1 h and washed with PBS. Caspase-3 activity was measured in fluorescence channel 2 using flow cytometry. Caspase-2 activity was analysed using zVDVAD-AFC (N-benzyloxycarbonyl-Val-Asp-Val-Ala-Asp-AFC) (Bachem, Heidelberg, Germany). Cells were lysed in 96-well plates and incubated with zVDVAD-AFC for 1 h at 371C. Fluorescence intensity was measured at 510 nm using 1420 Victor Multilabel Counter (Perkin-Elmer). As positive control for caspase activity cells were treated with 10 ng/ml TRAIL (R&D Systems, Inc.) and 1 mg/ml cycloheximide (Sigma). To inhibit caspase activity, the broad-range caspase inhibitor zVAD.fmk (Bachem) was used at 50 mM.
Cell cycle analysis
For cell cycle distribution, cells were washed with PBS and lysed in 0.5 ml GM solution (glucose, NaCl, KCl, Na 2 HPO 4 , KH 2 PO 4 , 0.5 mM EDTA) and 3 parts 95% ethanol. After centrifugation, the pellet was incubated in solution S (15 mg/ml propidium iodide, 50 mg/ml RNase in PBS) for 30 min at 371C and for an additional hour at 41C before flow cytometry.
Senescence-associated-bGal staining
Senescence-associated-bGal staining was carried out as described (Dimri et al., 1995) . Briefly, cells were incubated for 24 h at 371C with fresh staining solution (1 mg/ml X-Gal, 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, 2 mM MgCl 2 ).
RT-PCR
RNA was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany). For cDNA synthesis, 1 mg RNA was transcribed using ImPro-II Reverse transcription system (Promega, Madison, WI, USA). The following primers were used: p21 (AGGATCCATGTCAGAACCGGCTGG and CAGGATCC TGTGGGCGGATTAGGGCT), survivin (GCATGGGTGC CCCGACGTTG, GCTCCGGCCAGAGGCCTCAA), XIAP (CCATGTATAGTGAAGAAGCTAGAT, TGGTCACCAA TACCTGTGTAGTAG), Caspase-2 (AATGTGGAACTCCT CAACTTGCTG, TCCATCTTGTTGGTCAACCCC). RT-PCR for XIAP was carried out with 35 cycles of 1 0 at 951C, 551C and 721C. RT-PCR for survivin was carried out with 30 cycles of 1 0 at 951C, 621C and 721C. RT-PCR for p21 was carried out with 33 cycles of 1 0 at 951C, 541C and 721C. RT-PCR for Caspase-2 was carried out with 28 cycles of 1 0 at 951C, 541C and 721C. For all RT-PCRs we used GAPDH (30 cycles of 1 min at 951C, 551C and 721C) as control for transcription of equal amounts of cDNA. All RT-PCRs shown are representative of at least two independent experiments.
Surface and intracellular staining
To analyse expression of surface molecules, 5 Â 10 5 nonfixed cells were incubated with anti-CD29-APC, anti-CD49e-PE or anti-CD56-FITC (BD Biosciences), according to the company's instructions. Intracellular staining was performed as described previously (Roberts et al., 2001) . Briefly, cells were seeded on CultureSlides (BD Dako) and stained with 100 nM CMXRos (Molecular Probes) for 15 min at 371C. Cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 and stained with anti-Flag antibody for 2 h at 41C, followed by incubation with anti-mIgG-FITC for an additional hour at 41C. Pictures were taken at confocal microscopy using Leica TCS NT (Heidelberg, Germany). For analysis of multinucleated cells, cells were stained with 1 mM To-Pro-3 iodide (Molecular Probes) for 15 0 and representative pictures were taken at Leica TCS NT.
Chorion-Allantois-membrane assay and histology
Chorion-Allantois-membrane (CAM) assay was carried out as described previously (Kuefer et al., 2004) . Briefly, 1 Â 10 6 tumor cells were resuspended in 25 ml serum-free medium and 25 ml Matrigel Matrix (BD Biosciences) and implanted on fertilized chicken eggs on day 8 of incubation using a silicone ring of 6 mm diameter. Tumor cells with the surrounding CAM were sampled 4 days after seeding and fixed in 4% paraformaldehyde, paraffin embedded and cut in 5 mm sections. Sections were stained with 1 : 1 hematoxylin and 0.5% eosin for histopathology.
Abbreviations AIF, apoptosis-inducing factor; CAM, chorion allantois membrane; DEVD-D2R, Asp-Glu-Val-Asp-Rhodamin; FACS, fluorescence activated cell sorting; FLIP, FLICE inhibitory protein; IAPs, inhibitor of apoptosis proteins; Smac, second mitochondria derived activator of caspase; TRAIL, TNFrelated apoptosis inducing ligand; XIAP, X-linked inhibitor of apoptosis; zVAD.fmk, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone; zVDVAD-AFC, N-benzyloxycarbonyl-Val-AspVal-Ala-Asp-AFC.
